12.04K
·
08-20
$AMD 20260821 515.0 CALL$ Finally able to afford a bowl of Koh Brothers Pig Organ Soup at Tiong Bahru Hawker Centre. Always Long queue! 😋😋😋 $AMD 20260821 515.0 CALL$
AMD CALL
08-20 21:46
US20260821 515.0
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Buy Close | 0.10 1Lot(s) | +99.01% Closed |
TOPAh_Meng: Don't eat too much... high everything 😎😂
1.22K
·
08-20
8/20 Pre-Market Thoughts: Hard Assets Rampage
One-sentence theme: A massive rotation is underway — gold at 4,500, crude oil +3%, bitcoin short-squeeze rally (hard assets rampage), while U.S. stocks continue to pull back. Fiscal stimulus failed to suppress long-end rates, and risk appetite has shifted toward physical assets. I. Sentiment Focus: Hard Assets Surging Across the Board Gold breaks above 4,500: The U.S. Treasury announced at least a doubling of long-end repurchase scale (injecting liquidity) → gold surged to 4,500. However, pre-market Thursday saw the 30-year Treasury yield rebound sharply, returning to pre-announcement levels → fiscal stimulus failed to suppress long-end rates, and U.S. equities continued their pullback. Crude oil +3%, maintaining strong upward momentum. Bitcoin short squeeze! Surged to 72,000, with $2.7 bi
TOPGold above 4500 still tracks the same setup for me: sticky inflation plus softer real yields. The sharp move can cool off, but dips still look like the cleaner sell put window.
610
·
08-20
$AI Gains 5.17% as Cloud Capex Momentum Sparks a Software Rebound
$C3.ai, Inc.(AI)$ $C3.ai, Inc.(AI) Closes +5.17% at $10.38: AI Software Play Reclaims $10 Handle, $10.47 Resistance in Sight Latest Close Data: C3.ai finished Wednesday at $10.38 (+5.17%), with intraday range $9.74–$10.41. Price now sits 48.7% below its 52-week high of $20.22, but has bounced sharply from the $7.67 52-week low. Core Market Drivers: Enterprise AI sentiment firmed after peer CoreWeave's blowout earnings reinforced cloud capex strength. Short-covering likely amplified gains, with short volume ratio spiking to 37.91% on 8/18 before easing. No company-specific catalyst hit the tape, leaving the move macro- and momentum-driven. Technical Analysis: Volume hit 4.3329M shares (Volume Ratio 1.04), confirming participation. MACD flipped decisi
1.01K
·
08-20
RBC’s $230 Target Sends $ILMN Surging 8.87%
$Illumina(ILMN)$ Latest Close Data ILMN closed at $205.00 on Aug 20, 2026, up +8.87% (+$16.71) from prior close of $188.29. The stock traded just $2.00 below its 52-week high of $207.00, with intraday range of $192.68–$205.16. After-hours price hit $207.91, already breaching that level. Core Market Drivers RBC Capital Markets reaffirmed "Outperform" with a $230 target, citing accelerating clinical sequencing momentum and fading competitive concerns. Q2 earnings (reported Jul 30) beat on both EPS and revenue, with FY guidance of $45.2B–$46.2B above consensus. Life-science sector strength provided tailwind. Technical Analysis Volume surged to 2.09M shares (Volume Ratio 1.90), confirming institutional accumulation. MACD remains negative at -1.28 (DIF
971
·
08-20
$NFLX Gains 3.15% as Ackman Bet Adds Fuel to the Breakout
$Netflix(NFLX)$ $Netflix(NFLX) +3.15% Reclaims $80 as MACD Golden Cross Ignites Breakout Momentum Latest Close: $80.22 (+3.15%), just 36.7% below its 52-week high of $126.71, with intraday range $78.10–$81.16 on 31.46M shares traded. Core Market Drivers: Bill Ackman's Pershing Square disclosed a new NFLX stake, sparking institutional buying. Netflix also secured 2027 Women's World Cup rights for $200M, reinforcing its live-sports moat. Streaming sentiment stays risk-on. Technical Analysis: MACD histogram surged to +1.59 with DIF crossing firmly above DEA, confirming a fresh golden cross on the daily. RSI(6) at 72.8 signals strong bullish momentum, though approaching overbought. KDJ J-line at 82.8 shows upward extension without bearish divergence y
1.06K
·
08-20
$ADBE Rebounds as AI Software Rotation Fuels a Move Toward $289
$Adobe(ADBE)$ $Adobe (ADBE) +3.55%: AI Monetization Momentum Builds, Pivot Above $272 Targets $289 Reclaim 🎯 Latest Close: $272.47 (+3.55%) | Session Range: $261.67–$275.80 | 52W High: $370.86 Core Market Drivers: BofA upgraded ADBE's target to $220, triggering a se ntiment shift after Morgan Stanley's earlier downgrade. AI application software rotation continues—capital migrating from hardware infrastructure to monetization plays, lifting ADBE alongside CRM. Volume ratio of 1.32 confirms institutional participation. Technical Analysis: 📊 MACD histogram flipped positive (+2.92) with DIF (10.98) crossing above DEA (9.52), signaling bullish momentum. RSI(6) surged to 65.8 from 43.3 in four sessions, exiting oversold territory decisively. KDJ shows K
742
·
08-20
$INTU Rallies Into Q4 Results as the AI Software Trade Reawakens
$Intuit(INTU)$ $Intuit Inc.(INTU) +3.44%: AI Software Momentum Builds, $430 Resistance in Sight Latest Close Data: INTU closed at $362.47 (+3.44%) on Aug 20, with intraday range $349.32–$365.38. Still 49.6% below 52-week high of $719.10, but up 43.3% from 52-week low of $252.84. Core Market Drivers: AI application software sector continued its strong rebound, with peer strength lifting INTU ahead of its Aug 25 Q4 earnings release. Market consensus expects revenue of ~$4.27B (+13.95% YoY) and adjusted EPS of $3.58 (+34.66%), fueling pre-earnings accumulation. Citi recently maintained Buy with $457 target despite trimming from $591. Technical Analysis: MACD shows DIF 15.02 > DEA 12.44 with positive histogram 5.15, confirming bullish momentum. RSI
580
·
08-20
$UAA Rallies 3.55% as Short Interest Adds Fuel to the Rebound
$Under Armour Class A(UAA)$ $Under Armour (UAA) +3.55%: Oversold Rebound Ignites, $6.21 Resistance Test Looms Latest Close: $5.25 (+3.55%) | Amplitude 3.85% | Vol 10.42M (VR 1.22) | 52W Range: $4.13–$8.15 | Distance from 52W High: -35.6% Core Market Drivers: Short-covering dominated as UAA bounced from multi-week lows near $5.08 support. No company-specific catalyst; broader retail sentiment stabilized, while insider ownership remains anchored by Kevin Plank (12.91%) and BDT Capital (15.51%), limiting float-driven downside. Technical Analysis: Volume Ratio at 1.22 confirms active accumulation. MACD remains deeply negative (DIF -0.400, DEA -0.248, Histogram -0.303) — still bearish but histogram contraction hints at slowing downside momentum. RSI(6)
9.69K
·
08-20
Moderna Soars 177%: Has the First Personalized mRNA Cancer Therapy Arrived?
$Moderna, Inc.(MRNA)$Moderna and Merck’s personalized cancer therapy met its key goals in a Phase 3 melanoma trial, sending MRNA sharply higher and lifting the broader biotech sector. Biotech stocks have finally found a major catalyst. Moderna (MRNA) surged roughly 177%, while Merck (MRK) gained about 12.6%. BioNTech (BNTX), which is also developing mRNA-based cancer treatments, climbed nearly 22%. Biotech ETFs XBI and IBB rose about 5.9% and 6.6%, respectively. The catalyst was positive Phase 3 data for intismeran autogene, also known as V940 or mRNA-4157. The personalized mRNA therapy is being jointly developed by Moderna and Merck and tested in combination with Merck’s blockbuster immunotherapy drug Keytruda. The combination met
TOPOpportunity for the companiesModerna: High impact. Post-COVID revenue collapse left it needing a new growth engine. This de-risks the mRNA oncology platform and is one of its three planned commercial franchises. Melanoma peak sales estimates for the therapy (total, before split) are roughly $1–3+ billion (Barclays ~$3B by 2035; other views in the $1.4–2.5B range for melanoma). Moderna’s share is half. Bigger upside lies in ongoing trials (NSCLC, renal cell, bladder, etc.); optimistic analyst views (e.g., BofA unadjusted global peak ~$54B across indications; William Blair multi-billion to Moderna in NSCLC/RCC) treat it as potentially Keytruda-like in breadth. It helps path back to profitability and validates the platform for other programs. Stock roughly more than doubled (peaks ~150–177%), adding tens of billions in market cap (to ~$50–70B range before some profit
660
·
08-20
$PFE Rallies 3.63% as Lyme Vaccine Approval Pushes Shares Toward a 52-Week High
$Pfizer(PFE)$ $Pfizer (PFE)+3.63% Surge Nears 52-Week High, RSI Overbought Signal Flashes Latest Close: $28.24 (+3.63%), just $0.51 from 52-week high of $28.75. Volume 59.8M shares (1.93x avg ratio). Core Drivers: EMA approved Pfizer-Valneva Lyme disease vaccine application, igniting momentum. Broad pharma sentiment lifted by Moderna-Merck mRNA cancer vaccine Phase 3 success. Pfizer trades near multi-year highs on pipeline optimism. Technical Analysis: RSI(6) at 86.1 and RSI(12) at 77.6 — firmly overbought, signaling strong momentum but elevated pullback risk. MACD bullish with DIF 0.668 > DEA 0.474, histogram expanding at 0.388. KDJ-J at 93.3 confirms overbought extreme. Key Price Levels: Primary Support $27.58 (today's low), Strong Resistance
400
·
08-20
$AMGN Hits a 52-Week High as Q2 Beat and MariTide Focus Lift the Stock
$Amgen(AMGN)$ $Amgen (AMGN) +4.02% Surges to 52-Week High $442.36: Biotech Giant Breaks Multi-Month Resistance, $452 Target in Sight Latest Close: $442.36 (+4.02%), hitting a fresh 52-week high of $443.20. Price now sits 64% above the 52-week low of $269.77. 📈 Core Drivers: Q2 earnings beat across the board (EPS $6.29 vs $5.62 est; revenue $10.05B vs $9.43B est) and full-year guidance raise. AMGN terminated early-stage obesity drug AMG 513 to focus on Phase III MariTide, triggering multiple analyst target hikes. 💊 Technical Analysis: Volume ratio at 1.03 with $1.12B traded. RSI(6) at 88.5 and RSI(12) at 81.4 signal deeply overbought conditions. MACD histogram expanding to 4.89 with DIF (14.50) well above DEA (12.05), confirming strong bullish mome
250
·
08-20
$F Gains 4.09% as Jefferies Upgrade and EV Truck Plans Lift Ford
$Ford(F)$ $Ford (F) Surged +4.09%: Ford Reclaims $14.50, MACD Bull Cross Ignites $15 Target Zone 🚗💥 Latest Close Data Ford closed at $14.50 on Aug 20, 2026, up +4.09% (+$0.57), with volume of 50.81M shares (1.48x average ratio). Price sits just 18.4% below its 52-week high of $17.78 and well above the 52-week low of $11.11. Core Market Drivers Sector-wide auto strength: Stellantis +8%, Rivian +3.3%, GM +2.6% on Aug 19. Jefferies upgraded F from Hold to Buy on July 27, lifting target from $14.50 to $17.50. Ford confirmed mid-size electric truck launch from early 2027 at $28,350. Technical Analysis MACD shows a fresh bullish crossover: DIF (-0.028) has crossed above DEA (-0.025), with histogram narrowing to -0.006, signaling momentum shift. RSI(6) jump
175
·
08-20
$CHWY Gains 4.12% as Pet E-Commerce Strength and Short Squeeze Potential Build
$Chewy, Inc.(CHWY)$ $Chewy, Inc.(CHWY) +4.12% Rally Pushes Toward $24.18 High, Momentum Building for $25.95 Retest 📈 Latest Close Data: CHWY closed at $23.99 (+4.12%) on 2026-08-20, just 0.8% below the session high of $24.18. The stock now sits 44.9% below its 52-week high of $43.50, but 37.9% above the 52-week low of $17.40. Core Market Drivers: Pet e-commerce strength continues amid resilient consumer spending. Chewy's Autoship subscription model and expanding pet healthcare services are attracting renewed institutional interest. Short volume ratio remains elevated at ~21%, creating squeeze potential as price action improves. Technical Analysis: Volume reached 5.61M shares (volume ratio 0.98). MACD shows bearish momentum fading: DIF at 0.468 vs
331
·
08-20
$UBER Rebounds 4.53% as 20%+ Bookings Growth Restores Investor Confidence
$Uber(UBER)$ $Uber Technologies, Inc.(UBER) +4.53% to $78.04: Ride-Hailing Giant Regains Momentum, $80 Breakout in Sight 🚀📈 Latest Close Data: UBER closed at $78.04 (+4.53%) on Aug 20, 2026, bouncing from $73.97 low to $79.31 high. Still ~23% below its 52-week high of $101.99. Core Market Drivers: Sentiment recovered after recent Waymo-driven selloff as gross bookings growth remains above 20%. Food delivery expansion continues to outpace ride-hailing, reinforcing the platform's dual-engine narrative. Technical Analysis: Volume surged to 19.06M shares (1.24× ratio) confirming accumulation. MACD DIF (1.26) stays well above DEA (0.78) with positive histogram expanding. RSI-6 jumped to 67.9, RSI-12 at 61.8, both leaving oversold territory. KDJ J-value
523
·
08-20
$G Jumps 5.05% as Fresh Capital Inflows Revive the Rally
$Genpact(G)$ $Genpact(G) +5.05% Pop to $36.40: Momentum Building Toward $38.49 Resistance 🚀 Latest Close Data: G closed at $36.40 (+5.05%) on Aug 20, 2026, with intraday range $34.74–$37.15. Still -25.2% below 52W high of $48.64, but now +35.6% above 52W low of $26.85. After-hours at $36.40. Core Market Drivers: No company-specific news driving today's move. Broader sentiment appears risk-on following U.S. Treasury's expanded long-dated bond buyback stabilizing rates. G's +5% pop came on volume ratio 1.84x with 6.96% amplitude, signaling renewed institutional accumulation after 5-day capital outflow streak flipped to inflow (+1.53M on 8/14). Technical Analysis: MACD remains negative (DIF 0.908 < DEA 0.965, histogram -0.113) but is narrowing fast —
1.60K
·
08-20
Plunge! How Did Alibaba's Earnings Really Turn Out?
$Alibaba(BABA)$ released its first-quarter fiscal 2026 earnings report, with revenue of RMB 268.95 billion, roughly in line with market estimates (RMB 268.52 billion). However, adjusted ADS earnings came in at only RMB 8.52, far below the year-ago figure of RMB 14.75 and the estimate of RMB 11.28. Adjusted net income was RMB 20.72 billion, down 38% year-over-year and missing expectations. Adjusted EBITDA was RMB 39.14 billion, down 14% year-over-year but slightly above estimates. Other income for the quarter was RMB 28.8 billion, significantly below the estimate of RMB 61.15 billion. The company repurchased approximately 13.4 million shares for a total of $162 million. Profit contribution from Ant Group was $230 million. Following
TOPRevenue isn’t the issue. The real problem is that Alibaba’s AI investment is weighing heavily on profits. The market doesn’t need another AI story—it needs to see real commercialization and profit growth.
221
·
08-20
$AFRM Rallies 5.13% as Bernstein and BofA Strengthen the Bull Case
$Affirm Holdings, Inc.(AFRM)$ $Affirm Holdings, Inc.(AFRM) +5.13% Surge Clears $77, Bulls Eye $78.43 Resistance for Breakout Latest Close: $77.33 (+5.13%), intraday high $78.76, low $73.35. Now trading just 1.4% below resistance at $78.43 and 22.7% below 52-week high of $100. Core Drivers: Bernstein initiated coverage with Outperform rating, adding to recent BofA target hike to $93. Macro tailwind from stabilizing consumer credit and sustained BNPL adoption continue to support momentum. Technical Analysis: Volume came in at 2.93 million shares with Volume Ratio of 0.95, confirming participation without exhaustion. RSI(6) rebounded to 56.4 from 40.4, exiting oversold territory while RSI(24) sits at 52.8 — room to run before overbought. MACD flipped
2.27K
·
08-20
The Fever in Rates Broke. What Ran Hardest Was a Cancer Vaccine
Hello. The long end, which had been pressing on everything for three days, got held down on Wednesday. The 30-year Treasury yield first set a 19-year high intraday, then turned back after the US Treasury said it would at least double the size of its liquidity support buybacks in 10- to 30-year securities. The 30-year fell as much as 9 basis points to 5.19 per cent, closed near 5.20 per cent, and is down to 5.18 per cent today. But technology did not come back. $SPDR S&P 500 ETF Trust(SPY)$ closed up 0.21 per cent and $Dow Jones(.DJI)$ 0.22 per cent, and most of that came from healthcare while tech kept being sold. One headline put it plainly: the tech sell-off resumed an
TOPWhat will 500 tiger coins get me?: the “manifesting” million dollar blanket/throw rug! Hint hint[Miser]
1.28K
·
08-20
Pop Mart’s earnings have turned out to be a major disappointment!
Just now, Pop Mart released its 2026 interim results. The numbers show that first-half revenue came in at RMB 17.173 billion, up 23.8% year over year but well below the market expectation of RMB 19.975 billion. Adjusted net income was RMB 5.156 billion, also significantly below the expected RMB 6.665 billion. In the first half of 2026, The Monsters, which includes Labubu, generated RMB 4.45 billion in revenue. Twinkle Twinkle generated RMB 2.65 billion, while Crybaby generated RMB 1.63 billion. By region, Pop Mart’s domestic revenue for the first half of the year was RMB 12.2 billion, revenue from the Asia-Pacific region totaled RMB 2.58 billion, revenue from Americas totaled RMB1.89 billion, and revenue from Europe and other regions totaled RMB 0.51 billion. Overseas revenue fell signific
TOP23.8% revenue growth is not some disaster though. Feels more like expectations got drunk on last year's Labubu spike, especially overseas
327
·
08-20
$W Climbs 6.01% as Bernstein Upgrade Adds Fuel to the Post-Earnings Rally
$Wayfair(W)$ $Wayfair(W) +6.01% Surges Past $107, Eyes $120 as Momentum Builds Latest Close Data Wayfair closed at $107.80 (+6.01%) on Aug 20, 2026. Price is now just 10.2% below its 52-week high of $119.98, with intraday range $103.55–$107.92. Core Market Drivers Bernstein upgraded W to Outperform, lifting its target from $100 to $125. Oppenheimer also flagged Wayfair as a key beneficiary of home-goods recovery, citing share gains and margin improvement. The stock has extended its post-Q2 earnings breakout. Technical Analysis Volume reached 2.41M shares, with RSI(6) jumping to 67.3 and RSI(12) at 62.1 — bullish but not yet overbought. MACD histogram turned positive at +0.916, confirming renewed upward momentum. KDJ shows K-line crossing above D-line